What Is an Optimal A1C Level?: Why "In Range" Isn't Always "Optimal"

What Is an Optimal A1C Level?: Why "In Range" Isn't Always "Optimal"

Your lab report says "normal." Your doctor says "looks fine." But a nagging voice wonders: fine compared to what?

Hemoglobin A1C — also called HbA1c or glycated hemoglobin — is one of the most widely ordered blood tests in modern medicine. It reflects your average blood glucose over the past two to three months, and it has become a cornerstone biomarker for diagnosing and managing diabetes. But the clinical thresholds printed on your lab report were designed to catch disease, not optimize health. The difference between those two goals is enormous, and for many people, it's the gap between feeling acceptable and functioning at your best.

This article breaks down what an optimal A1C level looks like based on current research, how it relates to other inflammatory and metabolic markers, and what you can actually do about it.

---

What Is a Normal A1C Level?

Before we talk about optimal, it helps to understand what "normal" officially means.

According to the American Diabetes Association (ADA), HbA1c is interpreted as follows:

At first glance, anything below 5.7% looks like a green light. But research over the past decade has consistently shown that metabolic risk — including cardiovascular disease, cognitive decline, and early beta-cell dysfunction — begins increasing well below the 5.7% threshold.

A landmark analysis published in The Lancet (Emerging Risk Factors Collaboration, 2011; PMID: 21705069) pooled data from 102 prospective studies involving over 698,000 adults and found that cardiovascular risk associated with glycemic markers rose progressively across the "normal" range. In other words, a person at 5.6% is not at the same risk level as a person at 4.9%, even though both are labeled "normal."

This is why functional medicine practitioners and many endocrinologists now draw a sharper distinction between the reference range and the optimal range.

---

What Is an Optimal HbA1c Level?

While no single governing body has formally codified an "optimal" A1C target for non-diabetic adults, converging evidence points toward a sweet spot between 4.8% and 5.4%.

Here's how the evidence breaks down:

Cognitive protection: A study published in Neurology (Rawlings et al., 2017; PMID: 28615424) followed 831 participants over 20 years and found that higher A1C levels — even within the "normal" range — were independently associated with greater cognitive decline and hippocampal volume loss. Participants with A1C values above 5.5% showed measurably worse cognitive outcomes than those in the 4.8%–5.2% range.

Cardiovascular risk: The ARIC study (Selvin et al., 2010; PMID: 20200382), which followed more than 11,000 adults without diabetes for roughly 15 years, found that A1C levels as low as 5.5%–6.0% were significantly associated with increased risk of coronary heart disease, stroke, and heart failure — even after adjusting for traditional cardiovascular risk factors.

Mortality data: A large UK Biobank analysis found a U-shaped association, with the lowest all-cause mortality observed in the 5.0%–5.4% range. Both very low and prediabetic-range A1C values were associated with elevated risk, suggesting that optimization — not just avoidance of excess — is the right framework.

The takeaway: if your A1C is 5.6%, your doctor may tell you everything is fine. But based on longitudinal data, you're already on an upward risk trajectory. The goal isn't to stay below 5.7% — it's to target 5.0%–5.4% for genuine metabolic health.

---

What Is an Optimal CRP Level? (And Why It Matters for Glucose Metabolism)

A1C doesn't operate in isolation. One of the most important companion biomarkers for understanding metabolic health is high-sensitivity C-reactive protein (hs-CRP), a liver-derived protein that rises in response to systemic inflammation.

The connection between CRP and glucose regulation is bidirectional: chronic low-grade inflammation impairs insulin signaling, and elevated blood glucose drives further inflammatory cytokine production. This creates a feedback loop that can accelerate metabolic decline even in people whose A1C is technically "normal."

Clinical reference ranges typically flag CRP as elevated above 3.0 mg/L for cardiovascular risk purposes. But functional targets are considerably tighter:

A 2019 meta-analysis in Diabetes Care (Ahlqvist et al.) demonstrated that high CRP levels were independently predictive of glycemic progression — meaning people with elevated CRP were significantly more likely to progress from prediabetes to type 2 diabetes over a 5-year follow-up, regardless of their starting A1C. When both A1C and CRP are suboptimal, the risk compounds.

This is why a comprehensive metabolic picture requires looking at inflammation markers alongside glycemic ones — and why optimizing A1C in isolation, without addressing underlying inflammatory burden, often produces incomplete results.

---

What Is an Optimal Fibrinogen Level? (The Clotting-Glucose Connection)

Fibrinogen is a plasma protein involved in blood clotting and wound healing — but chronically elevated fibrinogen is also a significant marker of vascular inflammation and metabolic stress. Its relationship to glucose metabolism is less commonly discussed but clinically meaningful.

High blood glucose promotes a pro-coagulant state by increasing fibrinogen synthesis in the liver. Research published in Diabetes Care (Kannel et al.) and confirmed in multiple European cohort studies has shown that individuals with prediabetes and type 2 diabetes consistently have higher fibrinogen levels than metabolically healthy controls — and that elevated fibrinogen is an independent predictor of cardiovascular events in people with dysglycemia.

Functional ranges for fibrinogen differ from lab reference ranges:

For individuals trying to understand their full metabolic picture, fibrinogen is a useful adjunct to A1C and CRP — particularly if you have a family history of cardiovascular disease or are managing weight, blood pressure, or insulin resistance. Lifestyle strategies that reduce A1C (improved diet quality, resistance training, sleep optimization) also tend to reduce fibrinogen over time, which supports the case for addressing metabolic health holistically rather than chasing individual numbers.

---

Why Lab Reference Ranges Lag Behind the Science

Reference ranges printed on standard lab reports are statistical constructs — they reflect the middle 95% of a tested population, not the range associated with the lowest disease risk. In a population where more than 70% of American adults are overweight or obese, and where prediabetes prevalence exceeds 96 million adults (CDC, 2022), a "normal" range derived from that population has built-in drift.

This is sometimes called the "sick population problem" in functional medicine: when the reference group itself has elevated rates of metabolic dysfunction, the average no longer reflects what's biologically optimal. A 5.6% A1C may be average for a 50-year-old American, but it is not optimal.

This distinction — between statistically normal and physiologically optimal — is exactly the analytical lens that more sophisticated health platforms now apply to biomarker interpretation. Rather than asking "are you outside the danger zone," the more useful clinical question is: "where on the risk curve are you, and which direction are you trending?"

---

Lifestyle Levers That Move A1C Into the Optimal Range

For most non-diabetic adults, A1C is a highly modifiable biomarker. The following strategies have demonstrated clinically meaningful reductions in peer-reviewed research:

1. Reduce refined carbohydrate load. A meta-analysis in JAMA Internal Medicine (Ajala et al., 2013; PMID: 23371489) found that low-carbohydrate diets significantly reduced A1C compared to control diets — with effects sustained at 6 and 12 months.
2. Prioritize resistance training. Skeletal muscle is the primary site of glucose disposal. Progressive resistance training 2–3x per week increases GLUT4 transporter expression and improves insulin sensitivity independent of weight loss.
3. Optimize sleep. Even one week of partial sleep restriction (5–6 hours/night) has been shown to impair glucose tolerance and elevate cortisol — both of which drive A1C upward (Spiegel et al., The Lancet, 1999).
4. Address chronic stress. Cortisol promotes hepatic gluconeogenesis and peripheral insulin resistance. Chronically elevated cortisol is a significant driver of A1C creep in otherwise healthy adults.
5. Use evidence-based supplementation strategically. Several nutrients have demonstrated clinically meaningful effects on glycemic regulation — and this is where your formula can do meaningful work.

---

What This Means for Your Formula

Supplementation for glycemic optimization isn't about replacing lifestyle — it's about filling the gaps that diet and exercise can't fully close and addressing the co-occurring factors (inflammation, stress, mitochondrial function) that govern how well your body handles glucose.

At Ones, the AI health practitioner cross-references your A1C with related biomarkers — including CRP, fasting insulin, and cortisol if available — to identify the most relevant intervention targets. Rather than applying a generic glucose formula, the system calibrates to your specific findings.

For individuals whose A1C is elevated in the context of chronic stress and elevated cortisol, Ones includes KSM-66 Ashwagandha at 600mg — the dose used in the Chandrasekhar et al. randomized controlled trial (PMID: 23439798), which demonstrated significant reductions in serum cortisol. Since cortisol drives hepatic glucose production, reducing adrenal burden is a legitimate metabolic lever — one that often pairs well with Ones' proprietary Adrenal Support blend.

For individuals where systemic inflammation (elevated CRP, fibrinogen) is a co-driver of glycemic dysfunction, Omega-3 fatty acids (EPA/DHA) are a primary tool. A meta-analysis in Journal of Nutrition found that omega-3 supplementation significantly reduced hs-CRP in adults with metabolic risk factors, supporting insulin signaling by reducing inflammatory interference. You can read more about how omega-3s fit into a comprehensive anti-inflammatory protocol in our article on how omega-3 dosing affects cardiovascular markers.

For individuals with suboptimal mitochondrial efficiency as a background factor — common in people whose A1C is trending upward with age — CoQ10 as Ubiquinol at 200mg supports mitochondrial electron transport and has been shown to improve glycemic markers in metabolic syndrome populations (Hernández-Camacho et al., Frontiers in Physiology, 2018). Ubiquinol is the reduced, bioavailable form — meaningful when your formula needs the compound to actually reach target tissues.

These aren't generic picks. They're examples of how a personalized formula targets the mechanisms behind your specific biomarker pattern — which is why reading your metabolic blood panel results alongside your A1C gives a far more actionable picture than any single number in isolation.

If you're also looking at CRP as part of your workup, understanding the relationship between inflammation markers and supplement timing can help you stack these interventions more effectively.

---

Key Takeaways

• "Normal" A1C is not the same as "optimal" A1C. The standard reference range (below 5.7%) reflects disease diagnosis thresholds, not lowest-risk targets. Emerging research supports targeting 5.0%–5.4% for optimal metabolic and cognitive health.
• Cardiovascular and cognitive risk rise progressively through the normal range. Large cohort studies show that an A1C of 5.5%–5.6% carries meaningfully higher risk than 4.9%–5.2%, even though both are "non-diabetic."
• CRP and fibrinogen amplify A1C risk. These inflammation and coagulation markers interact with glucose metabolism and should be assessed alongside A1C for a complete metabolic picture.
• Lab reference ranges are population averages, not health targets. In a population with high rates of metabolic dysfunction, "average" encodes significant disease burden.
• A1C is highly modifiable. Diet quality, resistance training, sleep, and stress management all move this marker — and targeted supplementation can address the co-factors (inflammation, cortisol, mitochondrial function) that lifestyle alone doesn't fully resolve.
• Personalized formulas work differently from generic supplements. Ones uses your actual biomarker data — including A1C, CRP, and cortisol — to determine which ingredients and doses address your specific pattern, rather than applying a one-size-fits-all glucose formula.